Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations
Open Access
- 31 December 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-12
Abstract
Medication-related problems (MRPs) contribute significantly to preventable patient harm and global healthcare expenditure. Vulnerable populations, including Indigenous Australians (please note that the use of the term ‘Indigenous’ in this paper includes all Aboriginal and Torres Strait Islander people and acknowledges their rich traditions and heterogenous cultures.) and people living with severe and persistent mental illness (SPMI), may be at increased risk of MRPs. Pharmacist-led medication reviews can identify MRPs for targeted action. To characterize MRPs identified and recommendations made by community pharmacists during medication reviews conducted with Indigenous Australians and people living with SPMI. Participants were recruited through two Australian trials testing the feasibility and/or effectiveness of novel community pharmacist-led interventions, the Indigenous Medication Review Service (IMeRSe) feasibility study (June 2018–July 2019) and Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge) randomized controlled trial (September 2020–December 2021). Trained community pharmacists conducted medication reviews responsive to the cultural and health needs of participants. MRPs, MRP severity and pharmacist recommendations were documented and classified using an established classification system (DOCUMENT). MRP severity was assessed by pharmacists and an independent assessor. Data were analysed descriptively, and paired t-tests were used to compare severity ratings. Pharmacists identified 795 MRPs with 411 participants across both trials (n = 255 IMeRSe, n = 156 PharMIbridge). Non-adherence to medication was the most common (n = 157, 25.1%) and second-most common (n = 25, 14.7%) MRP in IMeRSe and PharMIbridge, respectively. Undertreatment was the second-most common MRP in the sample of Indigenous Australians (n = 139, 22.2%), and reports of toxicity/adverse reactions were most common in people living with SPMI (n = 41, 24.1%). A change in pharmacotherapy was the most frequent recommendation made by pharmacists (40.2% and 55.0% in IMeRSe and PharMIbridge, respectively). Severity ratings varied, with the majority being ‘Mild’ or ‘Moderate’ in both groups. Significant differences were found in the severity rating assigned by trial pharmacists and the independent assessor. Community pharmacists identified a range of MRPs experienced by two at-risk populations, most commonly non-adherence and toxicity or adverse reactions, when conducting medication reviews and proposed diverse strategies to manage these, frequently recommending a change in pharmacotherapy. These findings highlight the opportunity for more targeted approaches to identifying and managing MRPs in primary care and tailored community pharmacist-led interventions may be of value in this space. Trail Registration: Australian and New Zealand Clinical Trial Registry records (IMeRSe ACTRN12618000188235 registered 06/02/2018 & PharMIbridge ACTRN12620000577910 registered 18/05/2020).Keywords
Funding Information
- Department of Health and Aged Care, Australian Government
This publication has 40 references indexed in Scilit:
- Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophreniaResearch in Social and Administrative Pharmacy, 2015
- Education and training for community pharmacists in mental health practice: how to equip this workforce for the futureThe Journal of Mental Health Training, Education and Practice, 2014
- My Medicines and Me Questionnaire (M3Q): A novel tool for the assessment of subjective experiences of side effects in mental health consumersResearch in Social and Administrative Pharmacy, 2014
- A systematic review of hospitalization resulting from medicine‐related problems in adult patientsBritish Journal of Clinical Pharmacology, 2013
- Health inequity in the Northern Territory, AustraliaInternational Journal for Equity in Health, 2013
- DOCUMENT: a system for classifying drug-related problems in community pharmacyInternational Journal of Clinical Pharmacy, 2011
- Drug-Related Problems Detected in Australian Community Pharmacies: The PROMISe TrialAnnals of Pharmacotherapy, 2011
- Evaluating categorisation and clinical relevance of drug-related problems in medication reviewsPharmacy World & Science, 2010
- Drug-Related Problems in the Community SettingClinical Drug Investigation, 2006
- Better medication management for Aboriginal people with mental health disorders: a survey of providersAustralian Journal of Rural Health, 2004